ResearcherFred Hutch Cancer CenterActive in the last 2 years
Jonathan G. Sham
Matched on ORCID iD 0000-0002-1535-8182; OpenAlex author ID A5077460554. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 34
2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper
Papers 6
- Long-Term Survival Following Chemoradiation in Locoregional Recurrent Germline ATM Mutated Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.adro.2025.101742↗
- Evaluating surgeon communication of pancreatic cancer prognosis using the VitalTalk ADAPT framework. Last author DOI 10.1002/jso.27777↗
- Perioperative Chemotherapy and Chemoradiotherapy for Patients With Resectable and Borderline Resectable Pancreatic Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000002253↗
- CT Radiomics-Based Preoperative Survival Prediction in Patients With Pancreatic Ductal Adenocarcinoma. First author DOI 10.2214/ajr.20.23490↗
- Radical antegrade modular pancreatosplenectomy versus standard distal pancreatosplenectomy for pancreatic cancer, a dual-institutional analysis. Co-author DOI 10.21037/cco-20-6↗
- Pancreatic ductal adenocarcinoma contains an effector and regulatory immune cell infiltrate that is altered by multimodal neoadjuvant treatment. Co-author DOI 10.1371/journal.pone.0096565↗
Closest collaborators
The 25 strongest of 34 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Venu Gopal Pillarisetty · 4 shared papers, 2014–2025 · strength 0.65
- Paper Long-Term Survival Following Chemoradiation in Locoregional Recurrent Germline ATM Mutated Pancreatic Ductal Adenocarci… DOI 10.1016/j.adro.2025.101742↗
- Paper Evaluating surgeon communication of pancreatic cancer prognosis using the VitalTalk ADAPT framework. DOI 10.1002/jso.27777↗
- Paper Perioperative Chemotherapy and Chemoradiotherapy for Patients With Resectable and Borderline Resectable Pancreatic Aden… DOI 10.1097/mpa.0000000000002253↗
- Elena Gabriela Chiorean · 2 shared papers, 2023–2025 · strength 0.39
- Paper Long-Term Survival Following Chemoradiation in Locoregional Recurrent Germline ATM Mutated Pancreatic Ductal Adenocarci… DOI 10.1016/j.adro.2025.101742↗
- Paper Perioperative Chemotherapy and Chemoradiotherapy for Patients With Resectable and Borderline Resectable Pancreatic Aden… DOI 10.1097/mpa.0000000000002253↗
- Sita Kugel · 1 shared paper, 2025 · strength 0.24
- Rachael Ann Safyan · 1 shared paper, 2025 · strength 0.24
- Dushyant V. Sahani · 1 shared paper, 2025 · strength 0.24
- Lindsay K. Dickerson · 1 shared paper, 2024 · strength 0.22
- Jin Peng He · 2 shared papers, 2020–2021 · strength 0.20
- Christopher Lee Wolfgang · 2 shared papers, 2020–2021 · strength 0.20
- Gentry G. King · 1 shared paper, 2023 · strength 0.16
- Sam H. Whiting · 1 shared paper, 2023 · strength 0.16
- Andrew L. Coveler · 1 shared paper, 2023 · strength 0.16
- David Bing Zhen · 1 shared paper, 2023 · strength 0.16
- Alan Yuille · 1 shared paper, 2021 · strength 0.12
- Seyoun Park · 1 shared paper, 2021 · strength 0.12
- Noah S Rozich · 1 shared paper, 2021 · strength 0.12
- Satomi Kawamoto · 1 shared paper, 2021 · strength 0.12
- Elliot K. Fishman · 1 shared paper, 2021 · strength 0.12
- Ralph H. Hruban MD · 1 shared paper, 2021 · strength 0.12
- Alex B. Blair · 1 shared paper, 2021 · strength 0.12
- Linda Chi Hang Chu · 1 shared paper, 2021 · strength 0.12
- Xiangui Hu · 1 shared paper, 2020 · strength 0.08
- Ding Ding · 1 shared paper, 2020 · strength 0.08
- Michele Maiko Gage · 1 shared paper, 2020 · strength 0.08
- Gang Li · 1 shared paper, 2020 · strength 0.08
- Shiwei Guo · 1 shared paper, 2020 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.